Rutgers Institute for Health researchers found that the use of biologic and targeted therapies for children with juvenile idiopathic arthritis surpassed more typical therapies in recent years.
Rutgers Institute for Health researchers found that the use of biologic and targeted therapies for children with juvenile idiopathic arthritis surpassed more typical therapies in recent years.